DAVID HERNANDEZ to Prospective Studies
This is a "connection" page, showing publications DAVID HERNANDEZ has written about Prospective Studies.
Connection Strength
0.078
-
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncol. 2023 10; 145:106536.
Score: 0.024
-
Early detection of mandible osteoradionecrosis risk in a high comorbidity veteran population. Am J Otolaryngol. 2023 Mar-Apr; 44(2):103781.
Score: 0.023
-
Mechanical thrombectomy with a novel device: initial clinical experience with the ANA thrombectomy device. J Neuroradiol. 2022 Jun; 49(4):324-328.
Score: 0.020
-
End-organ testing for allergic rhinitis with fungi is poorly correlated with fungal sensitivity. Otolaryngol Head Neck Surg. 2013 Mar; 148(3):391-5.
Score: 0.012